MedPath

Clinical Values of Automated Electronic Alert for Acute Kidney Injury

Not Applicable
Completed
Conditions
Acute Kidney Injury
Interventions
Device: AKI alert
Registration Number
NCT02793167
Lead Sponsor
XinLing Liang
Brief Summary

Acute kidney injury (AKI) is common, serious and expensive.It is associated with significant mortality, morbidity and increased length of hospital stay.To improve clinical outcomes of AKI by early detection and timely referral to the renal,the investigators developed an electronic alert system which identifies all cases of AKI occurring in patients over 18 years.The system was also designed to collect data on AKI incidence one of the biggest tertiary hospital in China.

Detailed Description

A prospective, randomly controlled cohort study will be conducted agmong the patients with AKI who are detected by the use of AKI sniffer. The investigators chose to assess all inpatient serum creatinine results using a combination of "KDIGO" criteria.

The investigators randomly divided the patients into two groups:

1. Usual care : patients will receive standard clinical care by the primary physicians

2. AKI alert : an AKI alert will be sent to the the doctor in charge. Our team of kidney experts would give a suggestion if the the doctor in charge issue consultation applications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • adult patients with an Alert for AKI(based on KDIGO guidelines)
Exclusion Criteria
  • patients already on dialysis for AKI at the time of alert
  • patients with End stage renal disease
  • patients <18 years of age
  • patients dissenting from participation according to the Ethics application

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AKI alertAKI alertan AKI alert will send to the the doctor in charge.Our team of nephrologists would give suggestions if the doctor in charge issue consultation application.
Primary Outcome Measures
NameTimeMethod
Adverse events during hospitalizationfrom start of AKI to discharge,up to 4 weeks

cardiac shock/ need for intensive care/ cardiopulmonary resuscitation/ cardiac death/ death

Incidence of cardiovascular disease and its occurrence time followed up for 1 yearsOne year after discharge

heart failure/ acute coronary syndrome/ readmission/cardiac readmission/ cardiovascular intervention or surgery

AKI recovery/stop renal replacement therapyfrom start of AKI to discharge,up to 4 weeks

Glomerular filtration rate decreased/ new occurrence proteinuria/ original proteinuria aggravation

The AKI outcome and its occurrence time followed up for 1 yearsOne year after discharge

AKI recovery/stop renal replacement therapy

Secondary Outcome Measures
NameTimeMethod
Follow-up rate after dischargeOne year after discharge
Proportion of nephrology referralfrom start of AKI to discharge,up to 4 weeks
Diagnostic rate of AKI at dischargefrom start of AKI to discharge,up to 4 weeks

Trial Locations

Locations (1)

Nephrology Dept,Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath